메뉴 건너뛰기




Volumn , Issue 3, 2009, Pages

Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and neuropsychiatric symptoms in elderly patients with dementia

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; BENPERIDOL; BROMPERIDOL; CHLORPROMAZINE; CLOPENTHIXOL; CLOTIAPINE; CLOZAPINE; DROPERIDOL; FLUPENTIXOL; FLUSPIRILENE; HALOPERIDOL; LEVOMEPROMAZINE; MELPERONE; NEUROLEPTIC AGENT; OLANZAPINE; PENFLURIDOL; PIMOZIDE; PIPAMPERONE; PLACEBO; PROTHIPENDYL; QUETIAPINE; RISPERIDONE; SULPIRIDE; SULTOPRIDE; THIORIDAZINE; VERALIPRIDE;

EID: 70049103413     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007726     Document Type: Review
Times cited : (83)

References (22)
  • 1
    • 33645527991 scopus 로고    scopus 로고
    • Atypical antipsychotics for aggression and psychosis in Alzheimer's disease
    • Issue 10.1002/14651858.CD003476.pub2. [DOI: 10.1002/14651858.CD003476. pub2]
    • Ballard C, Waite J, Birks J. Atypical antipsychotics for aggression and psychosis in Alzheimer's disease. Cochrane Database of Systematic Reviews 2006, Issue 10.1002/14651858.CD003476.pub2. [DOI: 10.1002/14651858.CD003476.pub2]
    • (2006) Cochrane Database of Systematic Reviews
    • Ballard, C.1    Waite, J.2    Birks, J.3
  • 2
    • 43249092442 scopus 로고    scopus 로고
    • A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (The DART-AD Trial)
    • DOI 10.1371/journal.pmed.0050076, e76
    • Ballard C, Margallo Lana M, Theodoulou M, Douglas S, McShane R, Jacoby R, et al. A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DARTAD trial). PLoS Medicine 2008;5:e76. (Pubitemid 351649258)
    • (2008) PLoS Medicine , vol.5 , Issue.4 , pp. 587-599
    • Ballard, C.1    Lana, M.M.2    Theodoulou, M.3    Douglas, S.4    McShane, R.5    Jacoby, R.6    Kossakowski, K.7    Yu, L.-M.8    Juszczak, E.9
  • 3
    • 58649100881 scopus 로고    scopus 로고
    • The dementia antipsychotic withdrawal trial (DART-AD): Long-term follow-up of a randomised placebo-controlled trial
    • January 9, DOI: 10.1016/S1474-4422(08)70295-3
    • Ballard C, Hanney ML, Theodoulou M, et al. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. The Lancet January 9, 2009;DOI: 10.1016/S1474-4422(08) 70295-3.
    • (2009) The Lancet
    • Ballard, C.1    Hanney, M.L.2    Theodoulou, M.3
  • 6
    • 70049114483 scopus 로고    scopus 로고
    • US Food and Drug Administration Public Health Advisory. Accessed June 27
    • US Food and Drug Administration Public Health Advisory. Antipsychotics are not indicated for the treatment of dementia-related psychosis. http://www.fda.gov/cder/drug/InfoSheets/HCP/antipsychotics-conventional.htm Accessed June 27, 2008.
    • (2008) Antipsychotics Are Not Indicated for the Treatment of Dementia-related Psychosis.
  • 7
    • 29144508843 scopus 로고    scopus 로고
    • Global Prevalence of dementia: A Delphi consensus study
    • for Alzheimer's Disease International
    • Ferri C, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. for Alzheimer's Disease International. Global Prevalence of dementia: a Delphi consensus study. Lancet 2005;366:2112-2117
    • (2005) Lancet , vol.366 , pp. 2112-2117
    • Ferri, C.1    Prince, M.2    Brayne, C.3    Brodaty, H.4    Fratiglioni, L.5    Ganguli, M.6
  • 8
    • 0030428313 scopus 로고    scopus 로고
    • Behavioral and psychological signs and symptoms of dementia: A consensus statement on current knowledge and implications for research and treatment
    • DOI 10.1017/S1041610297003943
    • Finkel S, Costa e Silva J, Cohen G, Miller S, Sartorius N. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. International Psychogeriatrics 1996;8(Suppl 3):497-500. (Pubitemid 27229556)
    • (1996) International Psychogeriatrics , vol.8 , Issue.SUPPL. 3 , pp. 497-500
    • Finkel, S.I.1    Costa E Silva, J.2    Cohen, G.3    Miller, S.4    Sartorius, N.5
  • 9
    • 19144372322 scopus 로고    scopus 로고
    • Effects of memantine on behavioural symptoms in Alzheimer's disease patients: An analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies
    • DOI 10.1002/gps.1341
    • Gauthier S, Wirth Y, Mobius H. Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the neuropsychiatric inventory (NPI) data of two randomised, controlled studies. International Journal of Geriatric Psychiatry 2005;20:459-464 (Pubitemid 40716339)
    • (2005) International Journal of Geriatric Psychiatry , vol.20 , Issue.5 , pp. 459-464
    • Gauthier, S.1    Wirth, Y.2    Mobius, H.J.3
  • 10
    • 0033890206 scopus 로고    scopus 로고
    • Are behavioral and psychological symptoms of dementia associated with mortality in Alzheimer's disease?
    • Gilley DW. Are behavioral and psychological symptoms of dementia associated with mortality in Alzheimer's disease?. International Psychogeriatrics 2000;12:63-66 (Pubitemid 30599664)
    • (2000) International Psychogeriatrics , vol.12 , Issue.SUPPL. 1 , pp. 63-66
    • Gilley, D.W.1
  • 15
    • 29144517795 scopus 로고    scopus 로고
    • Primary care use of antipsychotic drugs: An audit and intervention study
    • DOI 10.1186/1744-859X-4-18
    • Mortimer A, Shepherd C, Rymer M, et al. Primary care use of antipsychotic drugs: an audit and intervention study. Annals of General Psychiatry 2005;4:18. (Pubitemid 41800140)
    • (2005) Annals of General Psychiatry , vol.4 , Issue.1 , pp. 18
    • Mortimer, A.M.1    Shepherd, C.J.2    Rymer, M.3    Burrows, A.4
  • 16
    • 47849102514 scopus 로고    scopus 로고
    • Antipsychotics for people with dementia
    • doi:10.1136/bmj.a602
    • O'Brien J. Antipsychotics for people with dementia. BMJ 2008;337: a602 doi:10.1136/bmj.a602.
    • (2008) BMJ , vol.337
    • O'Brien, J.1
  • 19
    • 12844274439 scopus 로고    scopus 로고
    • Pharmacological treatment of neuropsychiatric symptoms of dementia: A review of the evidence
    • DOI 10.1001/jama.293.5.596
    • Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia. A review of the evidence. JAMA 2005;293:596-608. (Pubitemid 40171242)
    • (2005) Journal of the American Medical Association , vol.293 , Issue.5 , pp. 596-608
    • Sink, K.M.1    Holden, K.F.2    Yaffe, K.3
  • 22
    • 33846905932 scopus 로고    scopus 로고
    • Prevalence and predictors of neuropsychiatric symptoms in cognitively impaired nursing home patients
    • DOI 10.1177/0891988706292762
    • Zuidema S, Koopmans R, Verhey F. Prevalence and Predictors of Neuropsychiatric Symptoms in Cognitively Impaired Nursing Home Patients. Journal of Geriatric Psychiatry and Neurology 2007;20:41-49 (Pubitemid 46233618)
    • (2007) Journal of Geriatric Psychiatry and Neurology , vol.20 , Issue.1 , pp. 41-49
    • Zuidema, S.1    Koopmans, R.2    Verhey, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.